Cargando…

BCG and SARS-CoV-2—What Have We Learned?

Despite controversy over the protective effect of the BCG (Bacille Calmette-Guérin) vaccine in preventing pulmonary tuberculosis (TB) in adults, it has been used worldwide since 1921. Although the first reports in the 1930s had noted a remarkable decrease in child mortality after BCG immunization, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kulesza, Jakub, Kulesza, Ewelina, Koziński, Piotr, Karpik, Wojciech, Broncel, Marlena, Fol, Marek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610589/ https://www.ncbi.nlm.nih.gov/pubmed/36298506 http://dx.doi.org/10.3390/vaccines10101641

Ejemplares similares

Dual Nature of Relationship between Mycobacteria and Cancer
por: Fol, Marek, et al.
Publicado: (2021)

Cytokine Receptors—Regulators of Antimycobacterial Immune Response
por: Druszczyńska, Magdalena, et al.
Publicado: (2022)

SARS: What have we learned?
Publicado: (2003)

What Have We Learnt about BCG Vaccination in the Last 20 Years?
por: Dockrell, Hazel M., et al.
Publicado: (2017)

What have we learned?
por: Rodgers, Peter, et al.
Publicado: (2021)

Emerging Infections: What Have We Learned from SARS?
por: Galvani, Alison P.
Publicado: (2004)

Neutrinos, what we have learned about them and what we have learned using them
por: Steinberger, J
Publicado: (2013)

Global SARS-CoV-2 genomic surveillance: What we have learned (so far)
por: Tosta, Stephane, et al.
Publicado: (2023)

We are infected with the new, mutated virus UO-COVID-19
por: Kulesza, Wojciech, et al.
Publicado: (2020)

Viral loads of SARS-CoV, MERS-CoV and SARS-CoV-2 in respiratory specimens: What have we learned?
por: Al-Tawfiq, Jaffar A.
Publicado: (2020)

From SARS to COVID-19: What lessons have we learned?
por: Liu, Qin, et al.
Publicado: (2020)

GOAL: What Have We Learned?
por: Leek, Timothy K Vander
Publicado: (2005)

What have we learned on mesons?
por: Moebes, J P
Publicado: (1972)

Psychological Interventions for Dementia Caregivers: What We Have Achieved, What We Have Learned
por: Cheng, Sheung-Tak, et al.
Publicado: (2019)

SARS-CoV-2 and allergy – what have we learned after two and a half years?
por: Brockow, Knut, et al.
Publicado: (2023)

Dendritic Cell Activity Driven by Recombinant Mycobacterium bovis BCG Producing Human IL-18, in Healthy BCG Vaccinated Adults
por: Szpakowski, Piotr, et al.
Publicado: (2015)

Artificial Intelligence in Urooncology: What We Have and What We Expect
por: Froń, Anita, et al.
Publicado: (2023)

What have we learned from LEP?
Publicado: (2001)

What have we learned from LEP?
Publicado: (2001)

What have we learned from LEP?
por: Ellis, Jonathan Richard
Publicado: (2001)

Genetics of Obesity: What have we Learned?
por: Choquet, Hélène, et al.
Publicado: (2011)

Higgs sector: What we have learned
por: Fiorini, Luca
Publicado: (2020)

Phage Therapy: What Have We Learned?
por: Górski, Andrzej, et al.
Publicado: (2018)

COVID-19: what have we learned?
por: Ho, Yeh-Li, et al.
Publicado: (2020)

Endometriosis and Reproduction: What We Have Learned
por: Garcia-Fernandez, Jaime, et al.
Publicado: (2020)

COVID-19: What have we learned?
por: Rafalowski, Chaim, et al.
Publicado: (2022)

Orthopaedic infections: what have we learned?
por: Lee, Christopher, et al.
Publicado: (2023)

Mycobacterium bovis Wild-Type BCG or Recombinant BCG Secreting Murine IL-18 (rBCG/IL-18) Strains in Driving Immune Responses in Immunocompetent or Immunosuppressed Mice
por: Fol, Marek, et al.
Publicado: (2022)

Metformin as Potential Therapy for High-Grade Glioma
por: Mazurek, Marek, et al.
Publicado: (2020)

Cerebral Small Vessel Disease
por: Litak, Jakub, et al.
Publicado: (2020)

MicroRNAs and cancer: what we know and what we still have to learn
por: Calin, George A
Publicado: (2009)

What have we learned and what do we still need to learn about nPDF?
por: Paakkinen, Petja
Publicado: (2021)

School Asthma Care During COVID-19: What We Have Learned and What We Are Learning
por: Abrams, Elissa M., et al.
Publicado: (2022)

Selenium and cancer – what have we learned from epidemiology and molecular epidemiology studies?
por: Jablonska, Ewa, et al.
Publicado: (2015)

S32.1 H5N1 and SARS — What have we learned?
Publicado: (2005)

SARS-CoV-2: One Year in the Pandemic. What Have We Learned, the New Vaccine Era and the Threat of SARS-CoV-2 Variants
por: Scialo, Filippo, et al.
Publicado: (2021)

Robotic Prostatectomy: What We Have Learned and Where We Are Going
por: Lee, David I.
Publicado: (2009)

Protease targeted COVID-19 drug discovery: What we have learned from the past SARS-CoV inhibitors?
por: Amin, Sk Abdul, et al.
Publicado: (2021)

What we have to know about corticosteroids use during Sars-Cov-2 infection
por: Ferraù, F., et al.
Publicado: (2020)

Implementation of HPV Tests in Latin America: What We Learned; What Should We Have Learned, and What Can We Do Better?
por: Godoy, Luani Rezende, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gekj50v20lg2nun06ipkasfdvl